News | May 18, 2026
Alembic Pharma Q4 revenue rises to Rs. 1,848 crore
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
US Generics grew 5% to Rs. 467 Crores for the quarter
EBITDA for Q1 FY25 is at Rs. 100 crore compared to Rs. 32 crore in the previous year
Subscribe To Our Newsletter & Stay Updated
